首页> 外国专利> NEW CELL, INDUCING AGENT OF ANTITUMOR EFFECT USING THE SAME, GENE THERAPY MEDICINE FOR CANCER, AND INDUCING METHOD OF ANTITUMOR EFFECT

NEW CELL, INDUCING AGENT OF ANTITUMOR EFFECT USING THE SAME, GENE THERAPY MEDICINE FOR CANCER, AND INDUCING METHOD OF ANTITUMOR EFFECT

机译:新细胞,使用其诱导抗肿瘤作用的药物,癌基因治疗药物以及抗肿瘤作用的诱导方法

摘要

PROBLEM TO BE SOLVED: To provide a new carrier cell excellent in stability and safety, and is also capable of intraperitoneal administration and systemic administration or the like, for example, in gene therapy for cancer.SOLUTION: A carrier cell of the present invention is a new cell specified by receipt number of NITE AP-01818, and a gene therapy medicine for cancer of the present invention includes the new cell of the present invention as a carrier cell for allowing oncolytic virus to work on a tumor cell. An inducing method of an antitumor effect of the present invention can be performed by using the gene therapy medicine for cancer, and includes a process of administering a virus-infected carrier cell obtained by making the carrier cell to be infected with oncolytic virus, to a patient.
机译:解决的问题:提供一种新的载体细胞,其稳定性和安全性优异,并且还能够例如在癌症的基因治疗中进行腹膜内给药和全身给药等。解决方案:本发明的载体细胞是本发明的用于癌症的基因治疗药物包括以收据编号为NITE AP-01818的新细胞为基础的本发明的新细胞作为允许溶瘤病毒在肿瘤细胞上起作用的载体细胞。本发明的抗肿瘤作用的诱导方法可以通过使用癌症的基因治疗药物来进行,包括将通过使溶瘤病毒感染的载体细胞获得的病毒感染的载体给药的过程。患者。

著录项

  • 公开/公告号JP2015195741A

    专利类型

  • 公开/公告日2015-11-09

    原文格式PDF

  • 申请/专利权人 EHIME UNIV;

    申请/专利号JP20140074181

  • 发明设计人 HAMADA YUKO;

    申请日2014-03-31

  • 分类号C12N5/09;A61K48/00;A61P35/00;A61K35/76;A61P43/00;A61K31/409;A61K33/26;A61K45/00;A61K47/42;C12N7/00;C07K14/535;C07K14/78;C12N15/09;

  • 国家 JP

  • 入库时间 2022-08-21 15:33:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号